Deppe Michael J's Form 4 filing
Quest Diagnostics Inc (DGX) · filed Nov 7, 2024
- Accession no.
- 0001022079-24-000204
- Filed
- Nov 7, 2024
- Trade date
- Nov 6, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 8 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.89M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Deppe Michael JCIK 0001771759 | Officer (SVP, Corp. Controller & CAO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2024 | Common Stock | MOption exerciseAcquired | +8,635 | $71.17 | +$614,552.95 | 43,576 | Direct | |
| Nov 6, 2024 | Common Stock | MOption exerciseAcquired | +10,120 | $66.51 | +$673,081.2 | 53,696 | Direct | |
| Nov 6, 2024 | Common Stock | SSaleDisposed | −2,100 | $152.70 | −$320,670 | 51,596 | Direct | |
| Nov 6, 2024 | Common Stock | SSaleDisposed | −2,400 | $153.98 | −$369,552 | 49,196 | Direct | |
| Nov 6, 2024 | Common Stock | SSaleDisposed | −4,135 | $154.74 | −$639,849.9 | 45,061 | Direct | |
| Nov 6, 2024 | Common Stock | SSaleDisposed | −2,600 | $152.71 | −$397,046 | 42,461 | Direct | |
| Nov 6, 2024 | Common Stock | SSaleDisposed | −2,331 | $154.03 | −$359,043.93 | 40,130 | Direct | |
| Nov 6, 2024 | Common Stock | SSaleDisposed | −5,189 | $154.74 | −$802,945.86 | 34,941 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2024 | Common Stock | MOption exerciseDisposed | −8,635 | $71.17 | −$614,552.95 | 0 | Direct | |
| Nov 6, 2024 | Common Stock | MOption exerciseDisposed | −10,120 | $66.51 | −$673,081.2 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.